Navigating Supply Chain Disruptions of Iodinated Contrast Agent for Neuroimaging and How Business Intelligence Can Help the Decision Process

R Bammer; S A Amukotuwa

doi:10.3174/ajnr.A7544

Navigating Supply Chain Disruptions of Iodinated Contrast Agent for Neuroimaging and How Business Intelligence Can Help the Decision Process

AJNR Am J Neuroradiol. 2022 Jul;43(7):944-950. doi: 10.3174/ajnr.A7544. Epub 2022 Jun 1.

Authors

R Bammer^{1

2}, S A Amukotuwa^{3

2}

Affiliations

¹ >From Monash Imaging, Monash Health, Clayton, Victoria, Australia roland.bammer@monash.edu.
² Department of Radiology, Monash University, Clayton, Victoria, Australia.
³ >From Monash Imaging, Monash Health, Clayton, Victoria, Australia.

Abstract

A recent coronavirus disease 2019-related shutdown of the main production facility of iohexol in China has led to massive shortages of iodinated contrast material across the globe. This shortage has also jeopardized neuroimaging. In this article, we describe remedies to reduce iodinated contrast material use for stroke imaging, which is its primary use in neuroimaging, that we have implemented in our hospital network.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Contrast Media*
Humans
Intelligence
Iohexol
Neuroimaging

Substances

Contrast Media
Iohexol